| Literature DB >> 6925982 |
N Roeslin, J M Lang, G Morand, J M Wihlm, J P Witz.
Abstract
Patients with resectable squamous cell carcinoma were randomly allocated after surgery to receive either no further treatment (57 patients) or a single intrapleural injection of BCG (61 patients). No significant improvement in survival was observed in patients treated with BCG, even when their disease was staged as N0. There was a slight trend for the recurrence rate to be lower in patients classed as N0, but this was not significant.Entities:
Mesh：
Substances：
Year: 1982 PMID： 6925982 DOI： 10.1007/bf00205383
Source DB: PubMed Journal: Cancer Immunol Immunother ISSN： 0340-7004 Impact factor: 6.968